Compare Koninklijke Philips NV (PHG) vs RLX Technology Inc (RLX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Koninklijke Philips NV vs RLX Technology Inc — how do they compare? Koninklijke Philips NV trades at $26.3 (market cap $25.89B), while RLX Technology Inc trades at $2.05 (market cap $2.47B). The key difference: Koninklijke Philips NV is far larger — about 10.5× RLX Technology Inc's market cap, and RLX Technology Inc pays the higher dividend (4.95%). Which is the better fit depends on your goals.
| PHG | RLX | |
|---|---|---|
Market Cap | $25.89B | $2.47B |
Sector | Health | Technology |
52-Week High | $32.91 | $2.73 |
52-Week Low | $25.02 | $1.79 |
Enterprise Value | $32.18B | $1.10B |
Dividend Yield | 3.81% | 4.95% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
PHG trades at $26.58, down 1.37% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported net income of $895 million in 2025, a significant recovery from prior losses, with a net margin of 5.5%. Recent FDA clearances for medical devices and AI integrations highlight ongoing innovation. Cash flow from operations remains positive at $1.17 billion for 2025, though net cash flow declined to $403 million.
The outlook is mixed: analyst consensus is neutral with 59% hold ratings, reflecting caution despite recent profitability improvements. Key risks include high debt levels, with debt-to-asset ratio at 25.44% in 2025, and competitive pressures in health technology. Upside potential hinges on execution of AI-driven growth initiatives and margin expansion, as noted in Seeking Alpha analysis on 2026-05-20.
RLX trades at $2.06, up 0.49% on the day, with a bullish technical signal from moving averages but overbought RSI readings. The company reported Q1 2026 revenue growth driven by international expansion, with 2025 net income of $921.87M and a net margin of 22.47%. Recent news highlights the company's cash-rich, debt-free position and its positioning in the growing global vaping market.
The outlook is mixed; strong fundamentals and market growth potential are offset by consecutive earnings misses and a single analyst's hold rating. Key risks include regulatory scrutiny in the vaping industry and execution challenges in international expansion. The stock presents a speculative opportunity for investors comfortable with sector-specific regulatory risks.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Koninklijke Philips NV
Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.
Read more on PHG →About RLX Technology Inc
RLX Technology Inc. is a leading e-vapor company in China, focusing on the research, development, and sale of e-vapor products. The company primarily operates under the RELX brand, offering a range of closed-system e-vapor products designed to deliver a high-quality user experience. RLX's business model is centered on product innovation, strong brand building, and a vast distribution network across China.
Read more on RLX →
